USP13 and central nervous system neoplasm: The therapeutic potential of miR‐367 was further confirmed in vivo, in an orthotopic xenograft model of aggressive embryonal CNS tumors initiated by OCT4A‐overexpressing cells (Daoy, USP13‐MED, or USP7‐ATRT) in Balb/C nude mice.